A SUMMARY OF CANADIAN NANOMEDICINE RESEARCH FUNDING: STRENGTHS AND NEEDS

  • ERIC MARCOTTE
  • RÉMI QUIRION
Conference paper
Part of the NATO Science Series book series (NAII, volume 239)

Abstract

The Canadian Institutes of Health Research (CIHR) has recently developed a major strategic initiative in the areas of regenerative medicine and nanomedicine. The present article presents a preliminary analysis of nanomedicine funding at CIHR (2000-2005), using a moderately stringent definition of nanomedicine.

Keywords

Encapsulation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Canadian Institutes of Health Research (June, 2003); http://www.cihr-irsc.gc.ca/e/16044.htmlGoogle Scholar
  2. 2.
    Canadian Institutes of Health Research (June, 2005); http://www.cihr-irsc.gc.ca/e/28268.htmlGoogle Scholar
  3. 3.
    Canadian Institutes of Health Research (January, 2006); http://www.cihr-irsc.gc.ca/e/29542.html Stem Cell Network (January, 2006); http://www.stemcellnet.ca/Google Scholar
  4. 4.
    Stem Cell Network (January, 2006); http://www.stemcellnet.ca/e/Google Scholar
  5. 5.
    Quirion, R., 2002, A Canadian experiment: INMHA. How to link up the brain via a virtual institute, Trends in Neuroscience, 25: 268-270.Google Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • ERIC MARCOTTE
    • 1
  • RÉMI QUIRION
    • 2
  1. 1.Associate Director, Regenerative Medicine and Nanomedicine Initiative, Canadian Institutes of Health Research (CIHR)Ottawa, OntarioCanada
  2. 2.Scientific Director, Institute of Neurosciences, CIHR - Institute of Neurosciences, Mental Health and Addiction, Douglas Hospital Research CentreMcGill UniversityQuebecCanada

Personalised recommendations